• LAST PRICE
    14.7700
  • TODAY'S CHANGE (%)
    Trending Up0.0200 (0.1356%)
  • Bid / Lots
    14.7000/ 2
  • Ask / Lots
    14.8500/ 10
  • Open / Previous Close
    14.7600 / 14.7500
  • Day Range
    Low 14.7500
    High 14.8450
  • 52 Week Range
    Low 11.5300
    High 15.8900
  • Volume
    426,294
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 14.75
TimeVolumeMACK
09:32 ET52914.77
09:34 ET645614.76
09:36 ET113114.775
09:38 ET30014.79
09:41 ET10014.78
09:45 ET50014.79
09:50 ET55014.82
09:52 ET10014.83
09:54 ET60514.8101
09:56 ET10014.815
09:59 ET183614.81
10:01 ET10014.8
10:08 ET123814.8
10:10 ET109214.785
10:12 ET10014.79
10:17 ET202314.78
10:32 ET10014.78
10:33 ET174614.78
10:35 ET10014.78
10:37 ET80114.78
10:42 ET14014.8
10:46 ET10014.805
10:51 ET70014.82
10:55 ET37414.82
11:00 ET10014.815
11:02 ET10014.815
11:04 ET10014.82
11:06 ET10014.82
11:09 ET40014.82
11:13 ET30014.83
11:18 ET20014.83
11:22 ET99814.835
11:27 ET10014.84
11:31 ET109514.83
11:44 ET150014.84
11:47 ET96614.84
11:49 ET40014.84
11:54 ET44014.84
11:58 ET20014.84
12:00 ET10014.84
12:03 ET130914.84
12:09 ET90014.83
12:16 ET10014.83
12:20 ET55014.825
12:21 ET10014.82
12:25 ET10014.825
12:27 ET10014.82
12:30 ET66714.81
12:32 ET10014.81
12:34 ET30014.79
12:36 ET10014.79
12:43 ET10014.78
12:50 ET626214.7777
12:56 ET10014.78
12:59 ET20014.76
01:01 ET10014.76
01:10 ET20014.77
01:15 ET20014.77
01:17 ET10014.765
01:24 ET10014.765
01:26 ET10014.76
01:28 ET20014.765
01:42 ET10014.76
01:44 ET143014.79
01:46 ET20014.785
01:53 ET20014.79
01:57 ET70014.79
02:00 ET80014.81
02:06 ET70014.8125
02:09 ET34014.82
02:18 ET32014.81
02:20 ET20014.815
02:24 ET10014.82
02:26 ET10014.815
02:29 ET119414.82
02:33 ET57614.81
02:36 ET10014.81
02:38 ET50014.8
02:42 ET10014.79
02:51 ET360014.8
02:56 ET10014.795
02:58 ET30014.8
03:00 ET20014.8
03:05 ET20014.795
03:07 ET10014.795
03:14 ET627514.76
03:16 ET30014.77
03:18 ET10014.76
03:20 ET10014.76
03:23 ET60014.77
03:25 ET20014.77
03:27 ET10014.7625
03:30 ET20014.77
03:32 ET10014.765
03:34 ET30014.765
03:36 ET20014.77
03:39 ET30014.76
03:41 ET1485314.75
03:43 ET10014.75
03:45 ET20014.75
03:48 ET30914.755
03:50 ET50014.75
03:52 ET595214.77
03:54 ET69114.77
03:56 ET1244114.77
03:57 ET64514.76
03:59 ET509114.77
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMACK
Merrimack Pharmaceuticals Inc
214.6M
-178.8x
---
United StatesOMER
Omeros Corp
216.9M
-1.2x
---
United StatesOVID
Ovid Therapeutics Inc
215.7M
-4.1x
---
United StatesINMB
INmune Bio Inc
211.8M
-7.7x
---
United StatesATNM
Actinium Pharmaceuticals Inc
214.6M
-4.1x
---
United StatesATOS
Atossa Therapeutics Inc
225.5M
-7.6x
---
As of 2024-03-29

Company Information

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. The Company does not have any ongoing research or development activities and is seeking potential acquirers for its remaining preclinical and clinical assets. The Company is entitled to receive contingent payments related to its sale of ONIVYDE to Ipsen S.A. and also its contingent payments related to its sale of MM-121 and MM-111 to Elevation Oncology, Inc. Its payments are payable by Ipsen upon approval by the United States Food and Drug Administration (FDA) of ONIVYDE for certain additional clinical indications. ONIVYDE is approved by the FDA in combination with fluorouracil (5-FU) and leucovorin (LV) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. The Company’s wholly owned subsidiaries include Merrimack Pharmaceuticals UK Limited and Merrimack Securities Corporation.

Contact Information

Headquarters
One Broadway, 14Th FloorCAMBRIDGE, MA, United States 02142
Phone
617-441-1000
Fax
617-491-1386

Executives

Chairman of the Board, President, Treasurer
Gary Crocker
Independent Director
Eric Andersen
Independent Director
Noah Levy
Independent Director
Ulrik Nielsen
Independent Director
Ana Radeljevic

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$214.6M
Revenue (TTM)
$0.00
Shares Outstanding
14.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.42
EPS
$-0.08
Book Value
$1.31
P/E Ratio
-178.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.